Report Detail

Request for Sample of this report

Other Global Personalized Cancer Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3624861
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Personalized Cancer Medicine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
The Global Info Research report includes an overview of the development of the Personalized Cancer Medicine industry chain, the market status of Breast Cancer (Monoclonal Antibodies, Personalized Cancer Vaccines), Lung Cancer (Monoclonal Antibodies, Personalized Cancer Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Cancer Medicine.
Regionally, the report analyzes the Personalized Cancer Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Cancer Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Personalized Cancer Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Cancer Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Personalized Cancer Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Cancer Medicine market.
Regional Analysis: The report involves examining the Personalized Cancer Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Cancer Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Personalized Cancer Medicine:
Company Analysis: Report covers individual Personalized Cancer Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Cancer Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Lung Cancer).
Technology Analysis: Report covers specific technologies relevant to Personalized Cancer Medicine. It assesses the current state, advancements, and potential future developments in Personalized Cancer Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Cancer Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Personalized Cancer Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Market segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
Market segment by players, this report covers
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Cancer Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Cancer Medicine, with revenue, gross margin and global market share of Personalized Cancer Medicine from 2019 to 2024.
Chapter 3, the Personalized Cancer Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Personalized Cancer Medicine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Cancer Medicine.
Chapter 13, to describe Personalized Cancer Medicine research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Personalized Cancer Medicine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Personalized Cancer Medicine by Type
    • 1.3.1 Overview: Global Personalized Cancer Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Personalized Cancer Medicine Consumption Value Market Share by Type in 2023
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Personalized Cancer Vaccines
    • 1.3.5 Other
  • 1.4 Global Personalized Cancer Medicine Market by Application
    • 1.4.1 Overview: Global Personalized Cancer Medicine Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Breast Cancer
    • 1.4.3 Lung Cancer
    • 1.4.4 Chronic Myeloid Leukaemia
    • 1.4.5 Bowel Cancer
    • 1.4.6 Other Cancer
  • 1.5 Global Personalized Cancer Medicine Market Size & Forecast
  • 1.6 Global Personalized Cancer Medicine Market Size and Forecast by Region
    • 1.6.1 Global Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Personalized Cancer Medicine Market Size by Region, (2019-2030)
    • 1.6.3 North America Personalized Cancer Medicine Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Personalized Cancer Medicine Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Personalized Cancer Medicine Market Size and Prospect (2019-2030)
    • 1.6.6 South America Personalized Cancer Medicine Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Personalized Cancer Medicine Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Personalized Cancer Medicine Product and Solutions
    • 2.1.4 Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Personalized Cancer Medicine Product and Solutions
    • 2.2.4 Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Personalized Cancer Medicine Product and Solutions
    • 2.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Amgen
    • 2.4.1 Amgen Details
    • 2.4.2 Amgen Major Business
    • 2.4.3 Amgen Personalized Cancer Medicine Product and Solutions
    • 2.4.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Amgen Recent Developments and Future Plans
  • 2.5 Celgene
    • 2.5.1 Celgene Details
    • 2.5.2 Celgene Major Business
    • 2.5.3 Celgene Personalized Cancer Medicine Product and Solutions
    • 2.5.4 Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Celgene Recent Developments and Future Plans
  • 2.6 Bayer
    • 2.6.1 Bayer Details
    • 2.6.2 Bayer Major Business
    • 2.6.3 Bayer Personalized Cancer Medicine Product and Solutions
    • 2.6.4 Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bayer Recent Developments and Future Plans
  • 2.7 Roche
    • 2.7.1 Roche Details
    • 2.7.2 Roche Major Business
    • 2.7.3 Roche Personalized Cancer Medicine Product and Solutions
    • 2.7.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Roche Recent Developments and Future Plans
  • 2.8 Astellas
    • 2.8.1 Astellas Details
    • 2.8.2 Astellas Major Business
    • 2.8.3 Astellas Personalized Cancer Medicine Product and Solutions
    • 2.8.4 Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Astellas Recent Developments and Future Plans
  • 2.9 Astrazeneca
    • 2.9.1 Astrazeneca Details
    • 2.9.2 Astrazeneca Major Business
    • 2.9.3 Astrazeneca Personalized Cancer Medicine Product and Solutions
    • 2.9.4 Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Astrazeneca Recent Developments and Future Plans
  • 2.10 Johnson & Johnson
    • 2.10.1 Johnson & Johnson Details
    • 2.10.2 Johnson & Johnson Major Business
    • 2.10.3 Johnson & Johnson Personalized Cancer Medicine Product and Solutions
    • 2.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.11 Agilent
    • 2.11.1 Agilent Details
    • 2.11.2 Agilent Major Business
    • 2.11.3 Agilent Personalized Cancer Medicine Product and Solutions
    • 2.11.4 Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Agilent Recent Developments and Future Plans
  • 2.12 Takeda
    • 2.12.1 Takeda Details
    • 2.12.2 Takeda Major Business
    • 2.12.3 Takeda Personalized Cancer Medicine Product and Solutions
    • 2.12.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Personalized Cancer Medicine by Company Revenue
    • 3.2.2 Top 3 Personalized Cancer Medicine Players Market Share in 2023
    • 3.2.3 Top 6 Personalized Cancer Medicine Players Market Share in 2023
  • 3.3 Personalized Cancer Medicine Market: Overall Company Footprint Analysis
    • 3.3.1 Personalized Cancer Medicine Market: Region Footprint
    • 3.3.2 Personalized Cancer Medicine Market: Company Product Type Footprint
    • 3.3.3 Personalized Cancer Medicine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Personalized Cancer Medicine Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Personalized Cancer Medicine Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Personalized Cancer Medicine Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Personalized Cancer Medicine Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Personalized Cancer Medicine Consumption Value by Type (2019-2030)
  • 6.2 North America Personalized Cancer Medicine Consumption Value by Application (2019-2030)
  • 6.3 North America Personalized Cancer Medicine Market Size by Country
    • 6.3.1 North America Personalized Cancer Medicine Consumption Value by Country (2019-2030)
    • 6.3.2 United States Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Personalized Cancer Medicine Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Personalized Cancer Medicine Consumption Value by Type (2019-2030)
  • 7.2 Europe Personalized Cancer Medicine Consumption Value by Application (2019-2030)
  • 7.3 Europe Personalized Cancer Medicine Market Size by Country
    • 7.3.1 Europe Personalized Cancer Medicine Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 7.3.3 France Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Personalized Cancer Medicine Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Personalized Cancer Medicine Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Personalized Cancer Medicine Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region
    • 8.3.1 Asia-Pacific Personalized Cancer Medicine Consumption Value by Region (2019-2030)
    • 8.3.2 China Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 8.3.5 India Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Personalized Cancer Medicine Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Personalized Cancer Medicine Consumption Value by Type (2019-2030)
  • 9.2 South America Personalized Cancer Medicine Consumption Value by Application (2019-2030)
  • 9.3 South America Personalized Cancer Medicine Market Size by Country
    • 9.3.1 South America Personalized Cancer Medicine Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Personalized Cancer Medicine Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Personalized Cancer Medicine Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Personalized Cancer Medicine Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country
    • 10.3.1 Middle East & Africa Personalized Cancer Medicine Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Personalized Cancer Medicine Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Personalized Cancer Medicine Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Personalized Cancer Medicine Market Drivers
  • 11.2 Personalized Cancer Medicine Market Restraints
  • 11.3 Personalized Cancer Medicine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Personalized Cancer Medicine Industry Chain
  • 12.2 Personalized Cancer Medicine Upstream Analysis
  • 12.3 Personalized Cancer Medicine Midstream Analysis
  • 12.4 Personalized Cancer Medicine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Personalized Cancer Medicine. Industry analysis & Market Report on Personalized Cancer Medicine is a syndicated market report, published as Global Personalized Cancer Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Personalized Cancer Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo